http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113424799-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2021-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113424799-B
titleOfInvention Construction method and application of a PDX model based on the modification of the osteogenic niche microenvironment
abstract The invention belongs to the technical field, in particular to a construction method and application of a PDX model modified based on an "osteogenesis niche" microenvironment. The construction method is as follows: human umbilical cord mesenchymal cells are placed on biologically derived bone to induce differentiation into osteoblasts, and the biologically derived bone loaded with osteoblasts is obtained, and implanted under the skin of mice, and then primary leukemia Cells or tumor cells were seeded subcutaneously at the implantation site of biologically derived bone in mice. The present invention constructs a novel microenvironment modified PDX model, which provides a new type of PDX model with high transplantation success rate, stable passage, and can effectively retain the biological characteristics of primary cells for studying the formation mechanism of drug resistance of leukemia or tumor cells and drug screening. Disease research models.
priorityDate 2021-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60481
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06435
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ0MUT8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48750
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01587
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48749
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28334
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01586
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62757
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04141
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11052
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29118
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9BDX4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25140
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51748
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06740

Total number of triples: 46.